Burger King was taken private in 2010 by 3G Capital, a New York-based investment firm, and will soon become publicly traded through a merger with a shell company.
Mervyn Jacobson read about Simons' bumpy journey and was smitten with the idea of finding value in junk DNA. In 1989 they formed GeneType and applied for their first patent covering noncoding regions and HLA. In 2000 GeneType pulled off a reverse merger with a publicly traded Australian shell company that formerly mined for gold.